Your session is about to expire
← Back to Search
Restorative Material
SDF vs ART + Fluoride Varnish for Tooth Decay
N/A
Waitlist Available
Led By Suchitra S Nelson, PhD
Research Sponsored by Case Western Reserve University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have at least one untreated active root or coronal carious lesion with ICDAS-II (2015) lesion severity code of 3 or greater
Male or female, aged 62 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline and 52 weeks
Awards & highlights
Study Summary
This trial is testing whether silver diamine fluoride or atraumatic restorative treatment + fluoride varnish is more effective in preventing tooth decay in low-income housing facilities.
Who is the study for?
This trial is for people aged 62 or older living in certain low-income housing facilities who have at least one untreated tooth decay lesion. They must be able to follow the study's procedures for a year and not have life-threatening diseases, allergies to silver/heavy metals, or severe gum disease.Check my eligibility
What is being tested?
The trial compares two dental treatments on older adults: Arm 1 uses a biannual application of silver diamine fluoride (SDF), while Arm 2 uses atraumatic restorative treatment (ART) with glass ionomer cement plus biannual fluoride varnish. Each group has 275 participants.See study design
What are the potential side effects?
Possible side effects include sensitivity reactions to SDF or materials used in ART, such as glass ionomer cement. There may also be temporary discomfort from the dental treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have at least one untreated cavity that is moderate or worse.
Select...
I am 62 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change between baseline and 52 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline and 52 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
caries arrest
Hypersensitivity
Secondary outcome measures
oral health quality of life: Participant questionnaire
prevention of new decay
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: A "simple medical strategy" consisting of SDFExperimental Treatment1 Intervention
The treatment will be bi-annual application (at baseline and 26 weeks) of topical 38% silver diamine fluoride (Advantage Arrest, Elevate Oral Care LLC., West Palm Beach, FL) following manufacturer's instructions and guidelines published by UCSF (2016).
Group II: A "typical dental strategy" consisting of ART + FVActive Control1 Intervention
Atraumatic Restorative Treatment (ART) will be a modification of the approach used by Lo and colleagues (2006), and the cavity restored at baseline with resin reinforced glass-ionomer cement (GIC) (GC Corporation, Japan). Participants in this arm will also receive biannual topical fluoride varnish application (FluoriMax, Elevate) according to manufacturer's instructions.
Find a Location
Who is running the clinical trial?
Patient-Centered Outcomes Research InstituteOTHER
550 Previous Clinical Trials
29,996,358 Total Patients Enrolled
Case Western Reserve UniversityLead Sponsor
299 Previous Clinical Trials
259,507 Total Patients Enrolled
Suchitra S Nelson, PhDPrincipal InvestigatorCase Western Reserve University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have severe gum or mouth sores.I have a serious, life-threatening medical condition.I have at least one untreated cavity that is moderate or worse.I am 62 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: A "typical dental strategy" consisting of ART + FV
- Group 2: A "simple medical strategy" consisting of SDF
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are participating in this medical study?
"Positive, the clinicaltrials.gov database reports that this research endeavour is currently in search of volunteers. As per its initial posting on September 18th 2019 and subsequent updates to February 8th 2022, 590 individuals are needed from 1 specific location."
Answered by AI
Are there still opportunities to enroll in this venture?
"Data hosted on clinicaltrials.gov indicates that this medical study, initially posted in September of 2019, is actively recruiting participants. The trial was last modified on February 8th 2022."
Answered by AI
Share this study with friends
Copy Link
Messenger